- Home
- ZIMV vs CRNX Comparison
ZIMV vs CRNX Comparison
Compare ZIMV & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZIMV
- CRNX
- Stock Information
- Founded
- ZIMV 2021
- CRNX 2008
- Country
- ZIMV United States
- CRNX United States
- Employees
- ZIMV N/A
- CRNX N/A
- Industry
- ZIMV Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- ZIMV Health Care
- CRNX Health Care
- Exchange
- ZIMV Nasdaq
- CRNX Nasdaq
- Market Cap
- ZIMV 262.9M
- CRNX 2.8B
- IPO Year
- ZIMV N/A
- CRNX 2018
- Fundamental
- Price
- ZIMV $10.25
- CRNX $30.00
- Analyst Decision
- ZIMV Hold
- CRNX Strong Buy
- Analyst Count
- ZIMV 2
- CRNX 10
- Target Price
- ZIMV $10.00
- CRNX $75.00
- AVG Volume (30 Days)
- ZIMV 131.7K
- CRNX 641.2K
- Earning Date
- ZIMV 07-31-2025
- CRNX 08-07-2025
- Dividend Yield
- ZIMV N/A
- CRNX N/A
- EPS Growth
- ZIMV N/A
- CRNX N/A
- EPS
- ZIMV N/A
- CRNX N/A
- Revenue
- ZIMV $443,551,000.00
- CRNX $760,000.00
- Revenue This Year
- ZIMV $1.96
- CRNX $402.12
- Revenue Next Year
- ZIMV $1.95
- CRNX $770.88
- P/E Ratio
- ZIMV N/A
- CRNX N/A
- Revenue Growth
- ZIMV N/A
- CRNX N/A
- 52 Week Low
- ZIMV $8.15
- CRNX $24.10
- 52 Week High
- ZIMV $22.40
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- ZIMV 69.67
- CRNX 44.17
- Support Level
- ZIMV $9.05
- CRNX $28.34
- Resistance Level
- ZIMV $9.08
- CRNX $30.01
- Average True Range (ATR)
- ZIMV 0.40
- CRNX 1.07
- MACD
- ZIMV 0.14
- CRNX -0.17
- Stochastic Oscillator
- ZIMV 100.00
- CRNX 36.41
About ZIMV ZimVie Inc.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.